Major Pharmaceuticals Recalls

12 recalls on record in the United States

drugs: 12
drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tab

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 T

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Ta

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Ta

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 T

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Ta

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Ta

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tab

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tab

Subpotent Drug

View recall details →

drugs Class II
2026-07-29

Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100

Subpotent Drug

View recall details →